ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

G STEVEN CHESSER M. D.

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,111Medicare Part D Prescriptions Filled, Including Refills

Rank: 11 out of 439

$699K Total Retail Price of All Prescriptions

Rank: 30 out of 439

505 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
30% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Georgia
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 505 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

18% of this provider’s 505 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

2% of this provider’s 10,128 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 3%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$58 was the average price of a prescription from this provider, compared to $103 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Georgia
AMLODIPINE BESYLATE 495 484 1 2
HYDROCODONE-ACETAMINOPHEN 441 317 S3 2 1
LEVOTHYROXINE SODIUM 407 360 3 9
SIMVASTATIN 364 306 4 3
LOSARTAN POTASSIUM 291 249 5 31
FUROSEMIDE 269 223 6 5
OMEPRAZOLE 262 216 7 6
METOPROLOL SUCCINATE 252 211 8 13
METFORMIN HCL ER 215 157 9 108
LISINOPRIL 197 174 10 4
HYDROCHLOROTHIAZIDE 175 172 11 18
METOPROLOL TARTRATE 168 154 12 11
NEXIUM 163 148 13 32
RANITIDINE HCL 158 101 14 39
CITALOPRAM HBR 157 100 15 34
PRAVASTATIN SODIUM 154 124 16 23
GABAPENTIN 154 105 16 7
ATORVASTATIN CALCIUM 153 153 18 12
ATENOLOL 138 129 19 24
POTASSIUM CHLORIDE 134 126 20 30
CYMBALTA 125 88 21 45
ZOLPIDEM TARTRATE 121 114 22 14
FLUTICASONE PROPIONATE 118 102 23 50
WARFARIN SODIUM 111 109 24 10
LOSARTAN-HYDROCHLOROTHIAZIDE 110 106 25 91
CLOPIDOGREL 109 95 26 16
CRESTOR 108 105 27 33
ALLOPURINOL 108 89 27 54
DIOVAN 104 85 29 65
ESCITALOPRAM OXALATE 102 87 30 123
AZITHROMYCIN 102 86 30 79
TRAMADOL HCL 102 100 30 21
PREDNISONE 92 71 33 17
FLUOXETINE HCL 90 88 34 105
MELOXICAM 87 67 35 40
PLAVIX 85 78 36 26
TRAZODONE HCL 74 70 37 35
DONEPEZIL HCL 73 73 38 22
SINGULAIR 73 59 38 139
SERTRALINE HCL 70 48 40 44
METFORMIN HCL 69 69 41 29
TRIAMTERENE-HCTZ 69 66 41 112
LEVOFLOXACIN 69 55 41 117
TAMSULOSIN HCL 69 69 41 15
GLIMEPIRIDE 67 50 45 61
HYDRALAZINE HCL 66 60 46 55
METHYLPREDNISOLONE 65 59 47 122
NAMENDA 64 64 48 20
OXYCODONE HCL 62 24 S2 49 25
SYNTHROID 61 55 50 84
GLIPIZIDE XL 61 51 50 406
AMOXICILLIN 59 45 52 268
VENLAFAXINE HCL ER 59 47 52 101
ESTRADIOL 56 43 R 54 89
GLIPIZIDE ER 55 44 55 190
FINASTERIDE 54 54 56 43
DILTIAZEM 24HR ER 54 52 56 167
CELEBREX 53 53 58 180
OXYBUTYNIN CHLORIDE ER 53 53 58 164
PREMARIN 51 49 R 60 109
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 23, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.